MaiLi Volume with Lidocaine (4 x 1ml)

MaiLi

Medical device – dermal filler

Cross-linked hyaluronic acid volumizing dermal filler with lidocaine

CE Marked Class III medical device under European medical device regulations for hyaluronic acid dermal fillers with lidocaine.
Manufactured under ISO 13485 Compliant quality management systems for medical devices.
Developed and controlled in line with regulatory requirements for injectable HA fillers, including biocompatibility, sterility and stability testing.

CE Marked Class III medical device under European medical device regulations for hyaluronic acid dermal fillers with lidocaine.
Manufactured under ISO 13485 Compliant quality management systems for medical devices.
Developed and controlled in line with regulatory requirements for injectable HA fillers, including biocompatibility, sterility and stability testing.
Subject to ongoing post Market surveillance and clinical performance evaluation as part of Sinclair Pharma’s quality and safety systems.

Cross-linked hyaluronic acid volumizing dermal filler with lidocaine

Description

MaiLi Volume with Lidocaine (4 x 1ml) is a versatile, volumizing hyaluronic acid dermal filler from Sinclair Pharma, developed using patented OxiFree Smart Spring technology. With a HA concentration of 21 mg/ml and lidocaine 3 mg/ml, it is designed to rejuvenate and revitalise the face by restoring malleable fullness and refined contours. MaiLi Volume is specifically indicated for volumising the cheeks and temples, contouring facial features, filling and smoothing deep skin depressions, and for facial reconstruction of volume loss such as HIV-associated lipoatrophy. The highly elastic, spring-like gel provides strong lift and structural support while preserving natural facial expression, often requiring less product to achieve optimal aesthetic outcomes. It is supplied as four 1 ml pre-filled syringes and is intended exclusively for injection by trained medical professionals.

Bnefits

Provides robust volumisation of cheeks, temples and other midface and upper-face areas.
Contours and sculpts facial features while maintaining natural expression.
Effectively fills and smooths deep facial skin depressions and folds.
Indicated for facial reconstruction in areas with volume loss, including HIV-associated lipoatrophy.
OxiFree Smart Spring technology preserves long HA chains, creating an elastic gel that moves naturally with facial dynamics.
High projection and lifting capacity mean less product is needed for comparable volumising results.
Contains 3 mg/ml lidocaine to improve patient comfort during injection.
Delivers long-lasting, natural-looking outcomes, typically around 12 months or longer depending on patient and treatment area.

Indications

Volumisation of the cheeks and temples.
Contour and definition of facial features requiring structural support and fullness.
Aesthetic treatment of pronounced/deep facial skin depressions.
Facial reconstruction of structural defects of congenital or medical origin, including volume loss due to HIV-associated lipoatrophy.
General restoration and augmentation of facial tissue volume to address age-related or disease-related volume loss.